Literature DB >> 28755019

Turning a blind eye: HTLV-1-associated uveitis in Indigenous adults from Central Australia.

Rusheng Chew1,2,3, Timothy Henderson4, Jaskirat Aujla4, Eline Whist4, Lloyd Einsiedel5,6.   

Abstract

PURPOSE: We describe the first two cases of HTLV-1 associated uveitis to be associated with HTLV-1c subtype infection.
METHODS: Case report.
RESULTS: Uveitis was demonstrated in two Indigenous Australian men, both of whom had high HTLV-1c proviral loads in peripheral blood. Visual outcomes were poor in each case.
CONCLUSION: Clinicians should be aware of HTLV-1c infection as a cause of uveitis in Australia, and HTLV-1 serology should be included in the basic uveitis work-up in HTLV-1-endemic areas.

Entities:  

Keywords:  Central Australia; HTLV-1; Indigenous; Uveitis

Mesh:

Year:  2017        PMID: 28755019     DOI: 10.1007/s10792-017-0659-3

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  18 in total

1.  Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP.

Authors:  M Nagai; K Usuku; W Matsumoto; D Kodama; N Takenouchi; T Moritoyo; S Hashiguchi; M Ichinose; C R Bangham; S Izumo; M Osame
Journal:  J Neurovirol       Date:  1998-12       Impact factor: 2.643

2.  HTLV-I/II seroprevalence in 55 Brazilian patients with idiopathic uveitis.

Authors:  S R Pinheiro; A B Carneiro-Proietti; M V Lima-Martins; F A Proietti; A A Pereira; F Oréfice
Journal:  Rev Soc Bras Med Trop       Date:  1996 Jul-Aug       Impact factor: 1.581

Review 3.  Inflammatory manifestations of HTLV-1 and their therapeutic options.

Authors:  Fabiola Martin; Graham P Taylor; Steven Jacobson
Journal:  Expert Rev Clin Immunol       Date:  2014-11       Impact factor: 4.473

4.  Clinical and immunologic features of human T-cell lymphotropic virus type I uveitis.

Authors:  K Yoshimura; M Mochizuki; S Araki; N Miyata; K Yamaguchi; K Tajima; T Watanabe
Journal:  Am J Ophthalmol       Date:  1993-08-15       Impact factor: 5.258

Review 5.  Human T-lymphotropic virus type I in Japan.

Authors:  K Yamaguchi
Journal:  Lancet       Date:  1994-01-22       Impact factor: 79.321

6.  Epidemiological Aspects and World Distribution of HTLV-1 Infection.

Authors:  Antoine Gessain; Olivier Cassar
Journal:  Front Microbiol       Date:  2012-11-15       Impact factor: 5.640

7.  Higher human T-lymphotropic virus type 1 subtype C proviral loads are associated with bronchiectasis in indigenous australians: results of a case-control study.

Authors:  Lloyd Einsiedel; Olivier Cassar; Emma Goeman; Tim Spelman; Virginia Au; Saba Hatami; Sheela Joseph; Antoine Gessain
Journal:  Open Forum Infect Dis       Date:  2014-05-28       Impact factor: 3.835

8.  Clinical associations of Human T-Lymphotropic Virus type 1 infection in an indigenous Australian population.

Authors:  Lloyd Einsiedel; Tim Spelman; Emma Goeman; Olivier Cassar; Mick Arundell; Antoine Gessain
Journal:  PLoS Negl Trop Dis       Date:  2014-01-16

9.  HTLV-1 uveitis.

Authors:  Koju Kamoi; Manabu Mochizuki
Journal:  Front Microbiol       Date:  2012-07-24       Impact factor: 5.640

10.  Human T-Lymphotropic Virus type 1 infection in an Indigenous Australian population: epidemiological insights from a hospital-based cohort study.

Authors:  Lloyd Einsiedel; Richard J Woodman; Maria Flynn; Kim Wilson; Olivier Cassar; Antoine Gessain
Journal:  BMC Public Health       Date:  2016-08-15       Impact factor: 3.295

View more
  6 in total

1.  Highlights from the HTLV-1 symposium at the 2017 Australasian HIV and AIDS Conference held jointly with the 2017 Australasian Sexual Health Conference, November 2017, Canberra, Australia.

Authors:  Lloyd Einsiedel; Damian Purcell; Shane Schinke; Katelin Haynes; Graham P Taylor; Fabiola Martin
Journal:  J Virus Erad       Date:  2018-01-01

Review 2.  The challenge of describing the epidemiology of HTLV in the Amazon region of Brazil.

Authors:  Ricardo Ishak; Marluísa de Oliveira Guimarães Ishak; Antonio Carlos R Vallinoto
Journal:  Retrovirology       Date:  2020-02-14       Impact factor: 4.602

3.  HTLV in South America: Origins of a silent ancient human infection.

Authors:  Ricardo Ishak; Marluísa de Oliveira Guimarães Ishak; Vânia Nakauth Azevedo; Luiz Fernando Almeida Machado; Izaura Maria Cayres Vallinoto; Maria Alice Freitas Queiroz; Greice de Lemos Cardoso Costa; João Farias Guerreiro; Antonio Carlos Rosário Vallinoto
Journal:  Virus Evol       Date:  2020-07-24

4.  Brazilian Protocol for Sexually Transmitted Infections 2020: human T-cell lymphotropic virus (HTLV) infection.

Authors:  Carolina Rosadas; Carlos Brites; Denise Arakaki-Sanchez; Jorge Casseb; Ricardo Ishak
Journal:  Rev Soc Bras Med Trop       Date:  2021-05-17       Impact factor: 1.581

5.  Prevalence and Risk Factors for HTLV-1/2 Infection in Quilombo Remnant Communities Living in the Brazilian Amazon.

Authors:  Wandrey Roberto Dos Santos Brito; Greice de Lemos Cardoso-Costa; Lourival Marques Roland Junior; Keise Adrielle Santos Pereira; Felipe Teixeira Lopes; Bernardo Cintra Dos Santos; Aline Cecy Rocha de Lima; Isabella Nogueira Abreu; Carlos Neandro Cordeiro Lima; Sandra Souza Lima; Izaura M Vieira Cayres Vallinoto; Eduardo José Melo Dos Santos; João Farias Guerreiro; Antonio Carlos Rosário Vallinoto
Journal:  Front Public Health       Date:  2022-03-30

Review 6.  Updates on HTLV-1 Uveitis.

Authors:  Koju Kamoi; Toshiki Watanabe; Kaoru Uchimaru; Akihiko Okayama; Seiko Kato; Toyotaka Kawamata; Hisako Kurozumi-Karube; Noe Horiguchi; Yuan Zong; Yoshihisa Yamano; Isao Hamaguchi; Yasuhito Nannya; Arinobu Tojo; Kyoko Ohno-Matsui
Journal:  Viruses       Date:  2022-04-12       Impact factor: 5.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.